RecruitingNCT04570163

Berlin Registry of Right Heart Interventions


Sponsor

Charite University, Berlin, Germany

Enrollment

200 participants

Start Date

Jun 16, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Interventional therapy mainly of tricuspid regurgitation (TriClip, Cardioband) for people with pulmonary regurgitation and tricuspid regurgitation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 120 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEInterventional therapy mainly of tricuspid regurgitation (TriClip, Cardioband)

Catheter-based therapy of valve diseases of the right heart with various devices (e. g. TriClip, Cardioband).


Locations(1)

Charité - Universitätsmedizin Berlin

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04570163


Related Trials